EMCOR. We perform behind the scenes to support the pioneers of the human genome.

 

 When genetic pioneers at a leading R&D firm set out to map the human genome, they turned to EMCOR for electrical and mechnical systems that regulated the specialized environment they needed to identify the building blocks of life. And when others in the groundbreaking biotech industry saw the potential for a complete map — that it could lead to breakthroughs in genetics-based treatments for cancer, heart disease, HIV, and other diseases, they also turned to EMCOR.

 

We helped create a brand new DNA sequencing facility to bring these extraordinary treatments to market. EMCOR has been helping biotech companies since the first attempts to crack the genetic code, and we continue to work with many well-known and respected names in this revolutionary industry.

 

 

  

The J. Craig Venter Science Foundaton Joint Technical Center, Maryland

Challenge: Transform an out-of-use warehouse into a state-of-the-art, multi-use R&D and teaching facilty.

 

Result: Value engineerig and design/build solutions on a fast-track construction schedule enabled this not-for-profit organization to be up and running.

Celera Genomics Corporation, Maryland

Challenge: Replace or upgrade the entire building infrastructure, creating a cutting-edge DNA-sequencing facility while in a fully occupied structure.

 

Result: A top-flight laboratory that supports Celera's quest to unravel the mysteries of the human genome.  

University of Texas

Challenge: Install air conditioning, ventilation and plumbing systems in a self-contained biomedical lab that handles the highest levels of potentially lethal biological agents.

 

Result: The project was completed on time with zero recordable accidents, enabling the University to advance its position as a leading provider of research in the biomedical field.

GlaxoSmithKline, United Kingdom

Challenge: To provide complete engineering management solutions to more than 4 million square feet of complex R&D and manufacturing facilities according to critical specifications.

 

Result: While EMCOR focuses on GlaxoSmithKline's unique facility requirements, GSK can focus on its global mission to improve the quality of human life by enabling people to do more, feel better and live longer.